Bausch Health, formerly Valeant Pharmaceuticals, received tentative U.S. approval to market the plaque psoriasis lotion Bryhali.

Collegium Pharmaceutical Inc said on Monday the U.S. Food and Drug Administration had tentatively approved its experimental opioid painkiller, with final approval depending on the outcome of a lawsuit filed […]